Form 8-K - Current report:
SEC Accession No. 0001104659-24-067485
Filing Date
2024-06-03
Accepted
2024-06-03 08:01:02
Documents
54
Period of Report
2024-05-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2416237d1_8k.htm   iXBRL 8-K 25973
2 EXHIBIT 99.1 tm2416237d1_ex99-1.htm EX-99.1 60312
6 GRAPHIC tm2416237d1_ex99-1img01.jpg GRAPHIC 105905
7 GRAPHIC tm2416237d1_ex99-1img02.jpg GRAPHIC 535468
8 GRAPHIC tm2416237d1_ex99-1img03.jpg GRAPHIC 209234
9 GRAPHIC tm2416237d1_ex99-1img04.jpg GRAPHIC 232731
10 GRAPHIC tm2416237d1_ex99-1img05.jpg GRAPHIC 163096
11 GRAPHIC tm2416237d1_ex99-1img06.jpg GRAPHIC 133067
12 GRAPHIC tm2416237d1_ex99-1img07.jpg GRAPHIC 223366
13 GRAPHIC tm2416237d1_ex99-1img08.jpg GRAPHIC 162539
14 GRAPHIC tm2416237d1_ex99-1img09.jpg GRAPHIC 141336
15 GRAPHIC tm2416237d1_ex99-1img10.jpg GRAPHIC 126244
16 GRAPHIC tm2416237d1_ex99-1img11.jpg GRAPHIC 140795
17 GRAPHIC tm2416237d1_ex99-1img12.jpg GRAPHIC 245254
18 GRAPHIC tm2416237d1_ex99-1img13.jpg GRAPHIC 202921
19 GRAPHIC tm2416237d1_ex99-1img14.jpg GRAPHIC 179107
20 GRAPHIC tm2416237d1_ex99-1img15.jpg GRAPHIC 163862
21 GRAPHIC tm2416237d1_ex99-1img16.jpg GRAPHIC 107971
22 GRAPHIC tm2416237d1_ex99-1img17.jpg GRAPHIC 171239
23 GRAPHIC tm2416237d1_ex99-1img18.jpg GRAPHIC 209837
24 GRAPHIC tm2416237d1_ex99-1img19.jpg GRAPHIC 257786
25 GRAPHIC tm2416237d1_ex99-1img20.jpg GRAPHIC 288423
26 GRAPHIC tm2416237d1_ex99-1img21.jpg GRAPHIC 215375
27 GRAPHIC tm2416237d1_ex99-1img22.jpg GRAPHIC 190675
28 GRAPHIC tm2416237d1_ex99-1img23.jpg GRAPHIC 246856
29 GRAPHIC tm2416237d1_ex99-1img24.jpg GRAPHIC 177185
30 GRAPHIC tm2416237d1_ex99-1img25.jpg GRAPHIC 92680
31 GRAPHIC tm2416237d1_ex99-1img26.jpg GRAPHIC 140058
32 GRAPHIC tm2416237d1_ex99-1img27.jpg GRAPHIC 189223
33 GRAPHIC tm2416237d1_ex99-1img28.jpg GRAPHIC 189464
34 GRAPHIC tm2416237d1_ex99-1img29.jpg GRAPHIC 119727
35 GRAPHIC tm2416237d1_ex99-1img30.jpg GRAPHIC 171804
36 GRAPHIC tm2416237d1_ex99-1img31.jpg GRAPHIC 116411
37 GRAPHIC tm2416237d1_ex99-1img32.jpg GRAPHIC 189255
38 GRAPHIC tm2416237d1_ex99-1img33.jpg GRAPHIC 252507
39 GRAPHIC tm2416237d1_ex99-1img34.jpg GRAPHIC 172526
40 GRAPHIC tm2416237d1_ex99-1img35.jpg GRAPHIC 167101
41 GRAPHIC tm2416237d1_ex99-1img36.jpg GRAPHIC 83641
42 GRAPHIC tm2416237d1_ex99-1img37.jpg GRAPHIC 136403
43 GRAPHIC tm2416237d1_ex99-1img38.jpg GRAPHIC 190828
44 GRAPHIC tm2416237d1_ex99-1img39.jpg GRAPHIC 228155
45 GRAPHIC tm2416237d1_ex99-1img40.jpg GRAPHIC 99796
  Complete submission text file 0001104659-24-067485.txt   10420489

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA iova-20240531.xsd EX-101.SCH 3003
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE iova-20240531_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iova-20240531_pre.xml EX-101.PRE 22351
57 EXTRACTED XBRL INSTANCE DOCUMENT tm2416237d1_8k_htm.xml XML 3702
Mailing Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

EIN.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36860 | Film No.: 241012029
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)